[4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone
C49H42F2N14O3S2 — CID 177253089
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone
[4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone (PubChem CID 177253089) has the molecular formula C49H42F2N14O3S2 and a molecular weight of 977.10 g/mol. Its IUPAC name is [4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone.
Molecular Properties
| Compound Name | [4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone |
|---|---|
| PubChem CID | 177253089 |
| Molecular Formula | C49H42F2N14O3S2 |
| Molecular Weight | 977.10 g/mol |
| Exact Mass | 976.30 |
| IUPAC Name | [4-[1-[1-[4-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]cyclopropanecarbonyl]cyclopropyl]piperazin-1-yl]-[6-[[4-(1,3-benzothiazol-6-yl)-5-fluoropyrimidin-2-yl]amino]-3-pyridinyl]methanone |
| SMILES | O=C(c1ccc(Nc2ncc(F)c(-c3ccc4ncsc4c3)n2)nc1)N1CCN(C2(C(=O)C3(N4CCN(C(=O)c5ccc(Nc6ncc(F)c(-c7ccc8ncsc8c7)n6)nc5)CC4)CC3)CC2)CC1 |
| InChI | InChI=1S/C49H42F2N14O3S2/c50-33-25-54-46(60-41(33)29-1-5-35-37(21-29)69-27-56-35)58-39-7-3-31(23-52-39)43(66)62-13-17-64(18-14-62)48(9-10-48)45(68)49(11-12-49)65-19-15-63(16-20-65)44(67)32-4-8-40(53-24-32)59-47-55-26-34(51)42(61-47)30-2-6-36-38(22-30)70-28-57-36/h1-8,21-28H,9-20H2,(H,52,54,58,60)(H,53,55,59,61) |
| InChIKey | VQGRLSDDKMZRII-UHFFFAOYSA-N |
| XLogP | 7.23 |
| TPSA | 191.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 977.10 |
| LogP ≤ 5 | 7.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177253089 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.